Hubert Serve

39PUBLICATIONS

239CO-AUTHORS

Molecular targetsHaematological tumoursHaematologyMedical virologyCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (39)

Sort by Publication Date:

|Jul 08, 2026

USP22 is a novel vulnerability regulating MEIS1 protein abundance and gene transcription in KMT2Ar acute leukemia.

|Apr 14, 2026

Inhibition of high CXCR4 with Motixafortide and absence of single-cell MRD predict outcome after AML consolidation.

Enise Ceran, Sonia Jaramillo, Anne Kathrin Merbach

|Apr 06, 2026

First-in-Human Study of IL15-Activated Cytokine-Induced Killer Cells After Allogeneic HCT Shows Durable Remission and Serotherapy-Associated Immune Reconstitution in Leukemia.

Eva Rettinger, Dirk Heckl, Martin Hutter

|Dec 08, 2025

Azacitidine to treat measurable residual disease in patients with MDS/AML: final long-term results of the RELAZA2 trial.

Anne Sophie Platzbecker, Julia-Annabell Georgi, Jan Moritz Middeke

|Aug 18, 2025

Arsenic Trioxide and All-Trans Retinoic Acid Combination Therapy for the Treatment of High-Risk Acute Promyelocytic Leukemia: Results From the APOLLO Trial.

Uwe Platzbecker, Lionel Adès, Pau Montesinos

|Aug 01, 2025

Disrupting tRNA modifications to target mitochondrial vulnerabilities in drug-resistant leukemia cells.

Cornelius Pauli, Michael Kienhöfer, Maximilian Felix Blank

Pageof 7

Frequent Collaborators

15 joint publications

Christoph Röllig

14 joint publications

Carsten Müller-Tidow

12 joint publications

Martin Bornhäuser

10 joint publications

Christian Thiede

10 joint publications

Stefan W Krause

10 joint publications

Uwe Platzbecker

Friedrich Stölzel

Andreas Neubauer

Sebastian Stasik

Frank Schnütgen

Frequent Collaborators

15 joint publications

Christoph Röllig

14 joint publications

Carsten Müller-Tidow

12 joint publications

Martin Bornhäuser

10 joint publications

Christian Thiede